Resultados de la búsqueda 371-380 of 4281 for Relapse

  1. Oncología (médica) - Ensayos clínicos

    ... Relapsed/Refractory Multiple Myeloma (RRMM). A Study of the Possible Use of a New Imaging Method with Glioma Tumors. Rochester, Minn. The purpose of this ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...

  3. Oncología (médica) - Ensayos clínicos

    ... Relapsed/Refractory Multiple Myeloma (RRMM). A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic ...

  4. Oncología (médica) - Ensayos clínicos

    A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...

  5. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

  6. Oncología (médica) - Ensayos clínicos

    A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...

  7. Oncología (médica) - Ensayos clínicos

    Ensayos clínicos · A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia ( ...

  8. Oncología (médica) - Ensayos clínicos

    ... Relapsed/Refractory Multiple Myeloma (RRMM). A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic ...

  9. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

  10. Oncología (médica) - Ensayos clínicos

    Ensayos clínicos · A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia ( ...